Anti-infective pharmaceutical products
Original notice title
Anti-infectieuze middelen
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
All documents and submissions must be in Dutch. Non-Dutch speakers may need translation services.
Requirement of no negative equity in last 3 years may exclude some tenderers.
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 11.1M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 48 MONTH
- Supply of anti-infective pharmaceutical products
- 43 lots for specific anti-infective agents
Show full summary
Open tender for a framework agreement for anti-infectious agents (pharmaceuticals) for AZ Sint-Lucas & Volkskliniek in Gent, Belgium. 43 lots for specific products. Framework duration 48 months. Award mostly based on lowest price. Only Dutch language accepted.
Risks
All documents and submissions must be in Dutch. Non-Dutch speakers may need translation services.
Requirement of no negative equity in last 3 years may exclude some tenderers.
Submission deadline in 12 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure
- Framework agreement for 4 years
- No variants allowed
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Lot 9
Lot 10
Lot 11
Lot 12
Lot 13
Lot 14
Lot 15
Lot 16
Lot 17
Lot 18
Lot 19
Lot 20
Lot 21
Lot 22
Lot 23
Lot 24
Lot 25
Lot 26
Lot 27
Lot 28
Lot 29
Lot 30
Lot 31
Lot 32
Lot 33
Lot 34
Lot 35
Lot 36
Lot 37
Lot 38
Lot 39
Lot 40
Lot 41
Lot 42
Lot 43
Buyer
Name
Vzw AZ Sint-Lucas & Volkskliniek
Location
Gent, BEL
Website
Identifier
BE0459265997
Lots (43)
LOT-0001
Amfotericine B IV liposomaal
Amfotericine B IV liposomaal
EUR 1.8M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
LOT-0002
Fluconazol compr
Fluconazol compr
EUR 78.1k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
LOT-0003
Fluconazol siroop
Fluconazol siroop
EUR 10k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
LOT-0004
Fluconazol IV
Fluconazol IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0005
Itraconazol compr
Itraconazol compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0006
Voriconazol compr
Voriconazol compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0007
Voriconazol IV
Voriconazol IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0008
Posaconazol compr
Posaconazol compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0009
Caspofungine IV
Caspofungine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0010
Anidulafungine IV
Anidulafungine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0011
Isavuconazole
Isavuconazole
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0012
Amoxicilline compr
Amoxicilline compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0013
Amoxiciline IV
Amoxiciline IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0014
Amoxicilline siroop
Amoxicilline siroop
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0015
Amoxicilline + Clavulaanzuur IV
Amoxicilline + Clavulaanzuur IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0016
Amoxicilline + Clavulaanzuur compr
Amoxicilline + Clavulaanzuur compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0017
Amoxicilline + Clavulaanzuur sir 125mg/5ml
Amoxicilline + Clavulaanzuur sir 125mg/5ml
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0018
Amoxicilline + Clavulaanzuur sir 250mg/5ml
Amoxicilline + Clavulaanzuur sir 250mg/5ml
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0019
Amoxicilline + Clavulaanzuur zakjes
Amoxicilline + Clavulaanzuur zakjes
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0020
Cefazoline IV
Cefazoline IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0021
Piperacilline + Tazobactam IV
Piperacilline + Tazobactam IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0022
Cefotaxim IV
Cefotaxim IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0023
Linezolid IV
Linezolid IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0024
Linezolid compr
Linezolid compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0025
Vancomycine IV
Vancomycine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0026
Meropenem IV
Meropenem IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0027
Ceftriaxone IV
Ceftriaxone IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0028
Ciprofloxacine IV
Ciprofloxacine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0029
Ciprofloxacine compr
Ciprofloxacine compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0030
Ceftazidim IV
Ceftazidim IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0031
Cefuroxim IV
Cefuroxim IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0032
Cefuroxim compr
Cefuroxim compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0033
Aciclovir compr
Aciclovir compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0034
Valganciclovir compr
Valganciclovir compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0035
Colistimethaat IV
Colistimethaat IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0036
Tigecycline IV
Tigecycline IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0037
Levofloxacine IV
Levofloxacine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0038
Levofloxacine compr
Levofloxacine compr
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0039
Clindamycine IV
Clindamycine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0040
Flucloxacilline IV
Flucloxacilline IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0041
Foscarnet IV
Foscarnet IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0042
Amikacine IV
Amikacine IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0043
Benzylpenicilline IV
Benzylpenicilline IV
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
Procurement Details
- Publication date
- 04 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Dutch
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 385556-2026
- Source notice ID
- 2ac3b37b-576f-4fbd-b225-4857feb87eb4
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
All documents and submissions must be in Dutch. Non-Dutch speakers may need translation services.
Requirement of no negative equity in last 3 years may exclude some tenderers.
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications